Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
  1. Home
  2. Products
  3. 5000358102

Medchemexpress LLC Mavorixafor trihydrochloride | 2309699-17-8 | 99.8% | C21H30Cl3N5 | 2 MG
SDP

Catalog No. 5000358102
Encompass_Preferred

Mavorixafor trihydrochloride is a potent, selective, and orally available CXCR4 antagonist. It inhibits the replication of T-tropic HIV-1 and can be used for the study of WHIM syndrome.

  • Potent, selective, and orally available CXCR4 antagonist
  • Inhibits replication of T-tropic HIV-1 (NL4.3 strain) in MT-4 cells with an IC50 of 1 nM
  • Inhibits replication of T-tropic HIV-1 (NL4.3 strain) in PBMCs with an IC50 of 9 nM
  • IC50 value of 13 nM against CXCR4 125I-SDF binding
  • Used for the study of WHIM syndrome

Catalog No. 50-003-58102 Supplier Medchemexpress LLC Supplier No. HY50101A2MG
May include imposed supplier surcharges.
Add to Cart
Add to Cart

missing translation for 'validMainframeMsg'

Mavorixafor trihydrochloride is a potent, selective, and orally available CXCR4 antagonist. It inhibits the replication of T-tropic HIV-1 and can be used for the study of WHIM syndrome.

  • Potent, selective, and orally available CXCR4 antagonist
  • Inhibits replication of T-tropic HIV-1 (NL4.3 strain) in MT-4 cells with an IC50 of 1 nM
  • Inhibits replication of T-tropic HIV-1 (NL4.3 strain) in PBMCs with an IC50 of 9 nM
  • IC50 value of 13 nM against CXCR4 125I-SDF binding
  • Used for the study of WHIM syndrome

Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.